“…We employed WFA as it is largely accepted as a marker for the majority of PNs and has been used in many species (Belichenko et al, 1999;Härtig et al, 1999;Cant and Benson, 2006;Ajmo et al, 2008;Morawski et al, 2012;Foster et al, 2014;Sonntag et al, 2015;. However, the molecular compositions of PNs may vary between brain regions and/or be differentially regulated with aging (Friauf, 2000;Brückner et al, 2003;Ajmo et al, 2008;Giamanco et al, 2010;Wang and Fawcett, 2012;Karetko-Sysa et al, 2014). Methods that use antibodies to CSPG molecules (aggrecan, brevican, phosphacan) can label populations of PNs that WFA does not reveal (Lurie et al, 1997;Ajmo et al, 2008;Karetko-Sysa et al, 2011;Blosa et al, 2013;Sonntag et al, 2015).…”